Skip to main content
Premium Trial:

Request an Annual Quote

Aurora Biosciences Licenses Technology From Xenometrix

Premium

BOULDER, Colo.--Aurora Biosciences of San Diego has gained access to the gene expression profiling technology for which Xenometrix here received a European patent in January. Xenometrix's non-exclusive license covers gene expression profiling utilizing methods other than high-density oligonucleotide microarrays.

Aurora also announced that Paul England has been promoted from vice-president discovery operations to senior vice-president research. England joined Aurora in February after 13 years in pharmaceutical research at SmithKline Beecham.

Filed under

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.